Calendar of Events
TRAM Annual Research Symposium 2020
June 10, 3-5:30pm
Register Here: https://stanford.zoom.us/webinar/register/WN_0KjQMelGQLmUHQBdATpFHA
The center for TRAM fosters education by offering a monthly seminar series and a research retreat. Our seminars include invited speakers who are recognized leaders in translational research and applied medicine. The sessions are open to all members of the campus community.
|11/11/15||2:00-4:00 pm||LK130||Personal Perspectives Lecture: Sandra Horning, MD: Executive Vice President, Global Development and Chief Medical Officer - Genentech/Roche|
|1/13/16||3:00-4:00 pm||LKSC Berg Hall||Personal Perspectives Lecture: John Hennessy, PhD: President of Stanford University; Professor of Electrical Engineering and Computer Science|
|2/3/16||3:00-4:00 pm||LK120||Personal Perspectives Lecture: Carla Shatz, PhD: https://med.stanford.edu/profiles/carla-shatz|
|4/6/16||2:00-3:00 pm||LK130||Personal Perspectives Lecture: Helen Blau, PhD: https://med.stanford.edu/profiles/helen-blau|
|5/20/16||9 am-4:00 pm||LKSC - Berg Hall||TRAM Annual Research Symposium|
* For Thursday MED221 lectures/seminars, please refer to the MED221 Class Schedule: http://med.stanford.edu/tram/education-and-resources/med221-course.html. MED221 lectures ARE OPEN TO PUBLIC
“Careers and Research in Academic Medicine: a personal perspective “
TRAM LECTURE SERIES
November 11, 2015 (2-4pm) – LK130
Sandra J. Horning, M.D. is the Chief Medical Officer, Head of Global Product Development and Executive Vice President of Global Development for Roche/Genentech. She is responsible for leading the medical and scientific strategies for the global clinical development portfolio in oncology. She leads and manages Genentech's team of oncology clinical scientists. She is an emerita professor of medicine (oncology) at Stanford University where she served as a tenured professor, practicing oncologist and investigator for more than two decades.
January 13, 2016 (3-4pm) – LK120
John L. Hennessy is the tenth President of Stanford University, as well as Professor of Electrical Engineering and Computer Science. He is one of the founders of MIPS Computer Systems Inc. as well as Atheros. Since assuming the presidency in October 2000, Hennessy placed an academic emphasis on interdisciplinary teaching and research that is also reflected in a physical transformation of the campus, all designed to heighten opportunities for intellectual collaboration between faculty and students through programs that are emulated by universities around the world. Under Hennessy's presidency, Stanford has undertaken major new academic initiatives to address important global challenges of this century. Interdisciplinary teaching and research has expanded dramatically with the creation of new cross-school, collaborative programs in human health, international affairs, environmental science and other areas.
February 3, 2016 (3-4pm) – LK120
Carla Shatz, PhD is director of Bio-X, Stanford University’s pioneering interdisciplinary biosciences program.
In 1976, Dr. Shatz was the first woman to earn a PhD in neurobiology at Harvard Medical School, where she studied with Nobel laureates David Hubel and Torsten Wiesel. In 1978, she joined the faculty as assistant professor of neurobiology at Stanford, where she was the first woman to receive tenure in the basic sciences.
Dr. Shatz is a member of the National Academy of Sciences, the American Academy of Arts and Sciences, the American Philosophical Society, and the Institute of Medicine and was recently elected as a Foreign Member of the Royal Society of London. She has been a Howard Hughes investigator and received numerous awards, including the Gill Prize in Neuroscience, the Society for Neuroscience’s Salpeter Lifetime achievement award, and the Ralph Gerard Prize in Neuroscience.
Dr. Shatz’s work has advanced understanding of fundamental principles of early brain development with the discovery that neuronal activity prior to birth is essential for later formation and refinement of connections in the visual system. Her work has important implications for understanding how the visual system refines its connections—work that has contributed to our understanding of critical periods of brain wiring in developmental disorders such as autism and schizophrenia.
April 6, 2016 (2-3pm) – LK130
Helen M. Blau, Ph.D. is an internationally recognized American biologist and the Donald E. and Delia B. Baxter Professor and Director of the Baxter Laboratory for Stem Cell Biology at Stanford University School of Medicine. She is known for establishing the reversibility of the mammalian differentiated state. Her landmark papers showed that nuclear reprogramming and the activation of novel programs of gene expression were possible, overturning the prevailing view that the differentiated state was fixed and irreversible. Her discoveries opened the door for cellular reprogramming and its application to stem cell biology. Dr. Blau has taught at the Stanford University School of Medicine since 1978. Her awards include the NIH Research Career Development Award and an NIH Merit Award. She is a member of the NIH committee created by Dr. Harold Varmus to oversee the Recombinant DNA Advisory Council (RAC) gene therapy trials.